The relationship between the human brain and human heart is comparable to that between a rider and a horse. Using a bridle, the rider controls the pace of his horse, whether trotting or cantering. Conversely, by observing the pace at which the horse moves, onlookers can deduce the method that the rider uses to control the horse as well as his thought processes. It is generally believed that a human being's heart and brain are hierarchically connected such that the heart receives the brain's commands through a central autonomic network[@b1]. The autonomic nervous system (ANS) correlates with the physiological and pathological states[@b2][@b3][@b4], in which changes typically reflect the heartbeat and brainwaves that communicate through regulatory central nervous system (CNS) signals. Because electroencephalography (EEG) alterations affect the physiological response pattern, the use of EEG has been proposed in practical applications to evaluate physiological responses[@b5][@b6]. In addition to EEG, a methodology for identifying relaxing states based on patterns from the heart rate and skin conductance has been investigated over the past decade[@b7][@b8]. However, medication and environmental factors may interfere with the results obtained for the skin conductance and heart rate. Hence, machine learning with the capacity to select features associated with physiological and pathological states has been used to identify emotion recognition systems[@b9][@b10]. According to methods that are acceptable in the field, the clinical applications of these measurements are limited by their multiple signals and complex mathematical models for physiological signals.

Compared with the previously proposed models, this study used a regression model and machine learning technique, which are referred to as change score analysis and generalized additive models, to evaluate relaxing states. These techniques require purely parametric values that are associated with the heart and brain. Our aim was to determine the optimal fitting of change score analysis using the difference between the pretest and post-test values obtained for electrocardiography (ECG) and EEG signals.

Researchers have begun assessing the human physiological states and ANS because ANS activity can be easily monitored through wearable sensors[@b11]. Hence, heart rate variability (HRV) analyses can be used to noninvasively assess autonomic function. Time- and frequency-based metrics[@b12][@b13] have been demonstrated to have prognostic value and can be linked to other clinical or biological prognostic metrics[@b14][@b15][@b16]. However, conventional linear HRV analyses, which are based on both time and frequency analysis, have several limitations due to the complex autonomic function of heartbeat dynamics, which consist of interconnected feedback loops[@b17]. For instance, although numerous researchers have performed a spectral estimation of biomedical signals, this estimate cannot sufficiently display the nonlinear and nonstationary properties of complex biological systems[@b12][@b18].

Recently, the sciences of complexity and classification algorithms have been closely related to HRV analysis, which characterizes nonlinear dynamics[@b19][@b20]. The present study investigated heartbeat features using two innovative analysis methods that are derived from nonlinear and nonstationary processes. The first method was a multiscale entropy (MSE) measurement method[@b21], which was applied using a nonlinear algorithm that provides the regularity pattern of a time series by analyzing the interplay between quantitative connotations and the correlations among individual subjects. The second method is called detrended fluctuation analysis (DFA)[@b22] and is used to evaluate the fractal correlation that causes a heart rate fluctuation originating from the interactive regulatory mechanisms. In addition, the short-term (∝~1~) and long-term (∝~2~) correlation exponents derived from the DFA analysis of heartbeat time series were calculated to clarify the fractal correlation property in a physiological system[@b23].

Although previous studies have yielded considerable valuable information that can be used to assess the human physiological states, many of the factors that can predict relaxation remain unexplored. The changes in the relaxing state of energy in EEG alpha bands are a critical indicator of the processes[@b24][@b25] associated with brain waves. Fourier-based spectral analysis has been widely used to investigate the spectra of EEG signals. However, the conventional Fourier transform only provides a coarse frequency estimate, which is unsuitable for short wavelengths. Hence, time-frequency transforms are used to calculate the alpha activity from clinical EEG data, and numerous methods are thus applied to estimate the time--frequency density of biomedical signals[@b26][@b27]. In particular, a short time window is applied to biomedical signals, and Fourier transforms are performed within this window as it slides across the range of data. This technique was incorporated in the change score analysis that was proposed in the present research, which could accurately predict people's relaxing states.

During the embryonic stage, the heart begins to beat before the brain is formed. It is not completely understood how the electrical signals between the brain and heart interact hierarchically. In this study, we tested the hypothesis that the complexity of cardiac electric activity can be used to predict the changes in encephalic electricity after stress. We adopted linear and nonlinear cardiac electrical activity features and the parameters associated with EEG alpha bands to recognize relaxing states.

Results
=======

Study patient demographics
--------------------------

A total of 117 patients were enrolled in the study. All patients tolerated the procedure well, and no clinical complications were noted during the index procedure or admission. Among them, thirty-three patients were excluded because of poor data recording and incomplete EEG recording, and the remaining 84 patients were selected for the final analysis. The clinical information of all patients (n = 84) are presented in [Table 1](#t1){ref-type="table"}. The mean age was 64.1 ± 11.8 years, and 69 were men. Sixty-five patients underwent both cardiac catheterization and coronary artery intervention (including stent implantation) in the index procedure (revascularization group). Nineteen patients underwent cardiac catheterization alone (nonrevascularization group) owing to the lack of significant stenosis in the index procedure.

Serum neurotransmitter measurement and ECG/EEG parameters in the revascularization and nonrevascularization groups
------------------------------------------------------------------------------------------------------------------

The differences in the serum neurotransmitter levels, HRV metrics and EEG parameters are presented in [Table 2](#t2){ref-type="table"}. In terms of serum neurotransmitters, the dopamine level was high in the revascularization group (231.60 ± 224.09 vs. 148.96 ± 201.66; *p* = 0.047). The differences in the orphanin FQ and serotonin levels between the groups were not statistically significant. In the EEG reading, the pre-procedure alpha activity, post-procedure alpha activity, and difference in the pre/post procedure alpha activity were comparable in both groups. The HRV metrics of pNN20 (pre-) and log-pNN20 (pre-) in the revascularization group were significantly different (0.4974 ± 0.2553 vs. 0.3567 ± 0.2267.66; *p* = 0.026 and −0.87 ± 0.68 vs. −1.27 ± 0.77; *p* = 0.026). The other HRV parameters were comparable in both groups.

Experimental framework
----------------------

[Figure 1](#f1){ref-type="fig"} shows the proposed framework, which consists of multiple analysis steps, including an overall variation analysis method (time- and frequency-based analysis), statistical method, and clinical data. Each ECG and EEG segment, with a time series of 4 min, was used for signal processing and statistical analysis. The novel ideal of the procedure is emphasized, and details of the procedure are presented in the Methods section. This procedure is completely based on the linear and nonlinear analysis of the pre- and post-test heartbeat. To improve the procedure and enhance the accuracy of predicting human's relaxing states, we included the post-catheterization EEG alpha waves and clinical data. In particular, we used STFT when there was a change in the encephalic electricity.

The statistics on the heartbeat and brainwaves were obtained using change-score analysis. Before model fitting, the continuous ECG and EEG parameters were analyzed using Spearman's rank correlation to remove a confounding variable, and GAMs were used to increase the prediction accuracy.

Data classification and definitions
-----------------------------------

ECG parameters were computed using two metrics, i.e., linear and nonlinear methods, as shown in [Supplementary Table S1](#S1){ref-type="supplementary-material"}. Some HRV metrics showed strong interactions between HRV and EEG, with a correlation coefficient of 0.8 (see [Supplementary Table S4 and S5](#S1){ref-type="supplementary-material"} for details). The correlation between MSE and conventional HRV analysis was nonsignificant for all patients. The EEG alpha activity was determined using STFT. The experiment involved the use of 52 continuous variables to investigate the role of relaxing states (post-test alpha activity). To enhance personalization and improve the investigation accuracy, the change score analysis derived 11 discrete variables of clinical data and 3 continuous serum neurotransmitter variables.

Before multiple regression model fitting, the continuous parameters of ECG and EEG were analyzed using Spearman's rank correlation to remove confounding variables from the test for continuous variables, which resulted in 23 continuous variables. Supplementary Table S2 shows the pretest, and the difference between the pre- and post-test was considered after determining the Spearman's rank correlation. To determine the prognostic value for the recognition of relaxed states, we proposed the following three methods: change-score analysis, change-score analysis using GAMs, and change-score analysis using GAMs without considering the EEG data obtained before stress (cardiac catheterization).

Change-score analysis
---------------------

[Table 3](#t3){ref-type="table"} shows the 84 patients who were analyzed using the change-score analysis. Six multiple regression parameters were evaluated. The pre-alpha activity, pre-meanNN, and difference-meanNN were the three main predictive factors used to recognize relaxing states on the basis of difference-alpha activity. Moreover, the pre-test alpha activity could influence the occurrence of difference-alpha activity because of its direct effect on the difference-meanNN and its indirect effect on pre-meanNN. Furthermore, the age, pre-log-Slopes 1--5, and pre-Slopes 1--5 were minor predictive factors for the difference-alpha activity. The results of the six regression parameters shed light on the mechanism of the major predictive factors of the difference-alpha activity, and the multiple R-squared value was 0.6509. This proposed method achieved an overall accuracy of 80.7% in recognizing changes in the EEG alpha waves.

Change-score analysis using generalized additive models
-------------------------------------------------------

The GAMs were used to detect the nonlinear effects of continuous covariates and identify appropriate cutoff points for discretizing a continuous covariate. GAMs enable the direct observation of the partial effect of a continuous covariance; therefore, the cutoff points can be easily selected. Supplementary Table S3 shows the continuous ECG parameters that were analyzed using the GAMs. The GAM of all patients is shown in supplementary Figs S1 to S19.

After stepwise variable selection, five GAM variables were included in the change-score analysis, and the multiple R-squared value increased to 0.7485, as shown in [Table 4](#t4){ref-type="table"}. The pre-alpha activity and difference-meanNN were the predominant predictive factors of difference-alpha activity. Furthermore, the difference-meanNN, difference-the ratio of LF over HF and GAM's HF were minor x values for difference-alpha activity. The proposed method achieved an overall accuracy of 86.5% in recognizing changes in EEG alpha waves.

Change-score analysis using generalized additive models without electroencephalography data obtained before stress (cardiac catheterization)
--------------------------------------------------------------------------------------------------------------------------------------------

This model was developed for wearable sensor nodes that, based on change-score analysis, identified linear and nonlinear indices of HRV, hypertension, and neurotransmitter levels without considering the electroencephalography data obtained before stress. As shown in [Table 5](#t5){ref-type="table"}, 12 multiple regression parameters were evaluated. Slopes 1--5 were the main predictive factors of the difference-alpha activity. In contrast to the change-score analysis and the change-score analysis using GAMs, nonlinear analyses are useful for predicting the difference-alpha activity. Furthermore, the difference-meanNN and difference-the ratio of LF over HF were minor predictive factors for the difference-alpha activity. In addition, the serum neurotransmitter levels, hypertension, and serotonin were included in the model. After stepwise variable selection, the multiple R-squared value was 0.4988. The proposed method achieved an overall accuracy of 70.6% in recognizing changes in EEG alpha waves. Although the prediction accuracy was relatively low, continuous EEG parameters need not be considered. Hence, HRV analyses are sufficient for assessing the autonomic function.

Discussion
==========

In movement control, the brain commands the motor system to produce the desired movements. The brain appears to control the motor system, but the afferent input from the motor system may strengthen or weaken the synaptic connections, thereby reorganizing the brain and leading to functional and structural changes in the brain. We posited that the brain interacts similarly with the heart. In our previous study[@b17], we demonstrated that there are correlations between the signal complexity of cardiac and cerebral activities. In the present study, we used cardiac catheterization as a stress event to evaluate the predictive power of post-stress brain activity by considering the ECG complexity parameters. As mentioned previously, EEG alpha waves represent a relaxing index[@b28]. Therefore, we developed three methods, which primarily involve ECG and EEG parameters, for assessing the human relaxing state after stress.

A numerical study of estimating the human relaxing state was developed in the literature[@b4]. The present method requires purely parametric values, and the human relaxing state can be calculated dynamically. This method mainly requires HRV metrics and the instantaneous power spectrum of EEG during the estimated relaxing states. Because this method was further incorporated with clinical data, such as the personal profile, diagnosis or serum neurotransmitter, it should be able to accurately characterize the relaxation response.

Two nonlinear methods, MSE and DFA, were used to quantify the heartbeat complexity and variability of heartbeat time series to provide information about the autonomic function. Because the connection between brain and cardiac activity has been demonstrated to be highly complex, HRV is a conventional metric for the pathophysiology and psychopathology[@b29]. Although conventional HRV metrics are reliable for predicting human relaxing states, the prediction accuracy is limited in the presence of frequent arrhythmias[@b30]. In this study, MSE and DFA were used to derive nonstationary and nonlinear dynamic changes from the heart rate time series[@b17][@b31][@b32]. The short-fitted slope (Slopes 1--5) of the curve obtained using MSE was considered when the change-score analysis was used in the change-score analysis. Moreover, when we used generalized additive models to increase the prediction accuracy, the short-fitted area (Areas 1--5) and long-fitted area (Areas 6--20) were used. Compared with conventional linear HRV indices, the nonlinear indices of the employed method had higher prediction ability for cardiac catheterization.

Previous studies have indicated that alpha activity reflects the selective cortical inhibition that is involved in global neural integration[@b33][@b34]. This feature of alpha activity has received considerable attention in cognitive neuroscience. The cognitive literature suggests that alpha activity is potentially involved in various other physiological processes, such as relaxing, or in specific regions of the brain[@b35]. Therefore, we hypothesized that alpha power is correlated with the relaxing state because the effect of neural inhibition could change emotions according to the physiological and pathological states. Therefore, short-time Fourier transform was used to quantify the spectral power of alpha activity from a 4-min time series of alpha activity. Our results showed that when the post EEG alpha waves were considered in the change-score analysis, the predictive accuracy increased from 70.6% to 80.7%.

Although we employed change-score analysis to estimate the human relaxing state after stress, numerous nonlinear HRV metrics (listed in Supplementary Table 3) were not considered. Consequently, the generalized additive models were fit to detect the nonlinear effects of continuous covariates[@b36]. In this study, generalized additive models were used to visualize the relationship of nonlinear HRV metrics with the difference between the pre- and posttest alpha wave responses. On the basis of graphical visualization, nonlinear HRV metrics can be used to identify the appropriate cutoff points for discretizing a continuous covariate (see Supplementary Fig. S1--S19). Our results for the ratio between the LF and HF and for the HF were considered in the prediction methods after fitting the generalized additive models. A comparison between the proposed prediction model and the proposed prediction model, without the generalized additive models, showed that the time-domain HRV metrics were the only parameters that could be considered to predict human relaxing states.

In this study, an innovative aspect of the method is the use of HRV and EEG to fit the regression model and the observed data for effect estimation and outcome prediction. Three methods were used for assessing the difference between the pre- and post-test alpha wave response. A change-score analysis model identified six mathematical parameters in the HRV and EEG that may facilitate predicting post-stress alpha waves. Conventional linear HRV analysis involves two metrics, the meanNN (pre-) and meanNN (difference), which provide positive and considerably low estimates. In addition, MSE analysis involves two metrics, Slopes 1--5 (pre-) and Log-areas 1--5 (pre-). Among the clinical parameters, only age was associated with high predictability. Furthermore, the change-score analysis model using GAMs identified 11 regression metrics, and five GAM variables were included in the predictive model. All GAM estimated values of the HRV analysis were positive at specific cutoff points. In addition, five predictive parameters that had been identified in previous studies were retained. Considering the practical application on wearable sensor nodes[@b11], the EEG data obtained before stress (cardiac catheterization) were not used in the change-score analysis. Five regression metrics are used in conventional linear HRV analysis. In the present study, sdNN(pre-), pNN20 (pre-), and LF/HF (difference) were new metrics that were added to the predictive model. The variables associated with clinical parameters included hypertension. An estimated value of serotonin was, for the first time, considered personalized in change-score analysis. Drugs that alter the serotonin levels are used to treat depression and generalized anxiety disorder. Therefore, it is reasonable for serotonin to be included in this model. This model shows that when we did not include the prestress alpha activity, the difference between the pre- and posttest alpha wave responses require more parameters to estimate the relaxing states. Of note, three predictable models did not include the treatment category of clinical data, which means that our proposed method can be applied to healthy subjects.

This study had numerous limitations. First, there was no control group in the entire relaxing condition, such in a home setting. All study subjects were patients with a relative anxiety status. Therefore, another study is needed to investigate the relationship between the brain and heart in subjects with a relaxing condition. Second, all ECG and EEG data were recorded in normal "free running" conditions, which implied the possible existence of interfering factors (e.g., physical activities and different relaxing states). Third, the database was based on data collected for a period of 1 h. Hence, dynamic noise or nonstationary artifacts might have affected the signal properties. Although the segments of ECC and EEG were detrended using a deterministic nonlinear method (empirical mode decomposition) discussed in previous studies[@b37], we did not assess the noise features or noise level to obtain more detailed information. Finally, some parameters related to the inhibitory characteristics reflected by EEG, such as cortical inhibitory mechanisms, were not considered in this study[@b38]. Therefore, it is necessary to develop a specific mathematical algorithm for quantifying global neural integration.

In conclusion, the method of predictive analysis demonstrates the potential of the interrelations between heartbeat and neural communication networks by using an accurate quantification equation involving change-score analysis, which is lacking in most previous studies. Accordingly, to increase the probabilistic accuracy, we developed a method to test our hypothesis. In this method, although conventional HRV analysis enables the quantification of a heartbeat, nonlinear methods provide additional information about the heartbeat complexity and fractal correlation. The proposed method achieved an overall accuracy of 80.7 and 86.5% in recognizing alpha-wave changes after stress basis on the change-score analysis and GAMs, respectively. Therefore, the complexity of cardiac electrical signals could be used to predict changes in the EEG alpha waves after stress.

Methods
=======

The ethics committee on human research of National Taiwan University Hospital (NTUH) approved the study (IRB-201206070RIC). All participants or their surrogates gave written informed consent. The investigation conformed to the principles of the Declaration of Helsinki.

Data collection
---------------

Patients with angina and positive stress tests who had undergone cardiac catheterization uneventfully were enrolled in this study from August 2012 to May 2014. One day before and immediately after cardiac catheterization, these patients underwent 1-hour EEG (Neuron-Spectrum-3, Neurosoft Company; Digital Neurophysiological Systems, Russia) monitoring with a sampling rate of 512 Hz and resolution of 16 bits. Continuous ECG recordings were extracted from the resting awake EEG for each patient. The RR interval (RRI) of ECG was determined using an automated detection algorithm, and the annotated file was carefully inspected and corrected for the extraction of the RRIs. Surface EEG was conducted using 19 electrodes of the international standard 10--20 system (FP2, F3, F4, FZ, C3, C4, CZ, P3, P4, PZ, O1, O2, F7, F8, T3, T4, T5, and T6). All patient data, including artifacts, such as eye movements, blinks, and muscle activities, were saved in text files for offline analysis on a laptop, and 4-min segments of the time-series were chosen from each file. Medical history, including demography and medication, was carefully recorded. Blood was sampled during cardiac catheterization.

Time- and frequency-based analysis
----------------------------------

Conventional HRV metrics were calculated in the time and frequency domains according to the guidelines developed by the Task Force of the European Society of Cardiology[@b12].

The patients were diagnosed using metrics in the time and frequency domains. The time domain metrics were as follows: the mean value of RRI time series (meanNN), standard deviation of the RRI time series (sdNN), root mean square of the differences between successive RRIs (rMSSD), percentage of absolute differences greater than 20 ms in normal RRIs (pNN20), and percentage of absolute differences greater than 50 ms in normal RRIs (pNN50). The frequency domain metrics were as follows: high-frequency component (HF, 0.15--0.4 Hz), low-frequency component (LF, 0.04--0.15 Hz), and the ratio between the low-frequency and high-frequency components (LF/HF), which were computed according to the average power spectrum.

Multiscale entropy analysis
---------------------------

MSE analysis can be used to estimate the complex pattern of a time series and evaluate the complexity of physiological signals on multiple time scales[@b21].

The MSE analysis method consists of two main steps: coarse-graining of the signals into different time scales and quantifying the degree of irregularity in each coarse-grained time series using sample entropy (SpEn)[@b39]. Coarse-graining yields a one-dimensional discrete time series {{*x*~1~,..., *x*~*i*~,..., *x*~N~}. In addition, the consecutive coarse-grained time series, {*y*^*τ*^}, which corresponds to the scale factor *τ*, can be constructed. To construct a coarse-grained series, the original time series should first be divided into *N*/*τ* nonoverlapping windows of length *τ*. Subsequently, the data points within each window should be averaged. Generally, each element of the coarse-grained series is calculated as follows:

With a scale factor of one, which corresponds to *τ* = 1, the coarse-grained series is exactly the same as the original one.

In addition, the MSE curve can be divided into long- and short-term curves. The different complexities of the scales can be useful for clinical categorization and can be divided into four types of parameters: (a) when only slope is considered, the first 5 scales are defined as the short-fitted slope (Slopes 1--5), and the final 15 scales are defined as the long-fitted slope (Slopes 6--20); and (b) when only the area is considered, the first 5 scales are defined as a short-fitted area (Areas 1--5), and the final 15 scales are defined as a long-fitted area (Areas 6--20). Although MSE analysis has been applied to physiological signals, the entropy values are sensitive to very-low-frequency noise and nonstationary artifacts, especially trends. Accordingly, the de-trending process should be performed prior to MSE analysis[@b37]. In the present study, the ensemble empirical mode decomposition method was adopted to remove the trend of the RRI signals.

Detrended fluctuation analysis
------------------------------

DFA can be used to quantify nonstationary and nonlinear dynamic changes in the heart rate time series. Recently, DFA has been widely used to analyze cardiac problems by inputting patients' RRI signals[@b40]. To calculate the scaling exponents in DFA, a given time series *x*(*i*), 1 ≤ i ≤ *N,* which should first be integrated as follows:

where *x*~*ave*~ is the mean of time series *x*(*i*). Subsequently, the integrated time series is divided into boxes of equal length n. Each box contains a least square line for fitting the divided time series, and the time series can be detrended by subtracting the local trend. The root-mean-square fluctuation of the integrated time series can be obtained as follows:

where the average fluctuations *F*(*n*) are represented as a function of the box size. The average fluctuations of the data sets indicate whether the crossover phenomenon exists between short- and long-term scales.

The short-term (\<11 beats, alpha_1) and long-term (\>11 beats, alpha_2) fractal correlation exponents were calculated to obtain a clearer understanding of the fractal correlation property of the biological system[@b23]. In addition, the heartbeat dynamics were characterized by a scaling exponent ∝, and the slope of the linear relationship was estimated according to the log-log plot of fluctuations versus box sizes.

Electroencephalography analysis using short-time Fourier Transform
------------------------------------------------------------------

In STFT, a short time window is applied to biomedical signals[@b41][@b42] and a series of Fourier transforms are performed within this window as the window slides across all data; STFT provides a time-frequency representation of the biomedical signal ([Fig. 2](#f2){ref-type="fig"}). STFT can provide an instantaneous estimate of the time-varying energy because the Fourier transform can be adapted for analyzing a localized signal. Mathematically, STFT is defined as follows:

where *w*(*t*) is a symmetric window function and *x*(*t*) is the signal to be transformed. *STFT*~*x*~(*τ*, *f*) uses a complex exponential basis function as the basis. The squared magnitude of STFT is referred to as a spectrogram:

where *τ* is discrete and *f* is continuous.

All analyses were performed using MATLAB (The MathWorks, Natick, MA, USA). The data were low-pass filtered with a cutoff frequency of 55 Hz to remove power line noise, and the power changes in the EEG following movement execution were estimated for all patients using a fast Fourier transform with windows of 1024 samples, a Hanning window with a width of 0.5 s, and a 70% overlap until all the EEG signals were analyzed.

The objective of using STFT is to assess the relaxing state of a subject exclusively through EEG analysis. Hence, the alpha activity is an essential metric for assessing relaxed wakefulness when visual processes are engaged by opening the eyes[@b43]. In the present study, we calculated only the alpha-activity-ratio related EEG signals using time--frequency analysis. The alpha-activity-ratio (AAR) obtained through EEG was investigated by comparing the alpha band (8--12 Hz) to the full-band EEG (1--55 Hz). Mathematically, the AAR is defined as follows:

where *E*(*t*~*k*~, *f*~*i*~) is the spectrum of the *i*-th bin in STFT, *t*~*k*~ denotes the time indices, and N is the total time length. On the basis of the obtained AARs, a significant level (*AAR*~*th*~) can be identified to quantify the intensity of the alpha waves.

In this study, we proposed a framework for calculating significant changes in the average time--frequency power density. This method consists of the following steps: (a) calculating the time--frequency power density, (b) dividing the time--frequency plane in which the alpha wave power density is calculated, (c) selecting a threshold for all channels, and (d) determining the energy change at the significant level for all channels. The process flow block diagram is presented in [Fig. 3](#f3){ref-type="fig"}.

Serum neurotransmitter measurement
----------------------------------

The levels of serum neurotransmitters, including orphanin FQ, dopamine, and serotonin, were measured. The orphanin FQ level was measured using an ELISA Kit (MyBioSource, San Diego, CA, USA), the serotonin level was measured using a serotonin ELISA Kit (Abcam, Cambridge, United Kingdom), and the dopamine level was measured using high-performance liquid chromatography.

Statistical analysis
--------------------

Statistical analysis was performed using the R 3.1.1 software (R Foundation for Statistical Computing, Vienna, Austria). A two-sided *p* value less than 0.05 was considered statistically significant. Data were expressed as the mean ± standard deviation. Differences in the serum neurotransmitter levels between the groups of patients were assessed using the Mann-Whitney U Test. Continuous data were assessed using the Mann-Whitney U Test, and categorical data were assessed using Fisher's exact test. The statistical analysis consisted of Spearman's rank correlation, a stepwise variable selection method, and change-score analysis.

The objective of conducting a regression analysis of the change scores (i.e., the difference between the pre- and posttest response) was to determine one or a few parsimonious regression models that fit the observed data well for effect estimation and outcome prediction. To ensure that the analysis quality was high, basic model-fitting techniques for variable selection, change-score analysis of pre- and posttest data, and regression diagnostics and remedies (e.g., ensuring that multicollinearity was not present and detecting influential cases) were applied. Before model fitting, the continuous ECG and EEG parameters were analyzed using Spearman's rank correlation to remove confounding variables. The significance level for the confounding effects was set to be greater than 0.8.

The stepwise variable selection procedure (with iterations between the forward and backward steps) was used to identify the optimal candidate final regression model. All relevant univariate significant and nonsignificant covariates (listed in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}) and some of their interactions were included in the variable list to be selected. The significance level for entry and stay was conservatively set to 0.15. Subsequently, the optimal candidate final regression model was manually identified by dropping the covariates with *p* values greater than 0.05, one at a time, until all regression coefficients were significantly different from zero.

The change-score analysis was used for changing subject *i* by Δ*Y*~*i*~ = *Y*~*i*1~ − *Y*~*i*0~, where *Y*~*i*0~ and *Y*~*i*1~ are the measured continuous pre- and posttest response variables, respectively[@b44]. Furthermore, the regression analysis of the mean change between two groups can be defined as follows:

where Group = 0 denotes the control group and Group = 1 denotes the treatment group; mathematically, . *X*~*i*1~, *X*~*i*2~, \..., *X*~*ik*~ are the other covariates that can affect the mean of the continuous response variable and is the random error. As a general rule, when Δ*Y*~*i*~ = *Y*~*i*1~ − *Y*~*i*0~ is specified as the response variable, the baseline response *Y*~*i*0~ must be introduced on the right-hand side of the regression equation.

The *R*^2^ statistic (0 ≤ *R*^2^ ≤ 1) for a linear regression model represents the correlation between the observed and predicted response values and indicates how much of the response variability is explained by the covariates in the linear regression model.

Finally, generalized additive models (GAMs)[@b45] were used to increase the prediction accuracy. The GAMs were fit to detect the nonlinear effects of continuous covariates and identify appropriate cutoff points for discretizing a continuous covariate. Thus, we obtained unbiased estimates of the covariates' effects and more accurate response predictions.
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![Overview of the experimental design for signal processing and statistical analysis.\
(**a**,**b**) Conventional HRV metrics were calculated in the time and frequency domains. (**c**) STFT is a type of spectral analysis with a fixed-width window and yields an instantaneous estimate of the time-varying energy. (**d**) Clinical information on the control and coronary artery disease (CAD) patients. (**e**) The continuous ECG and EEG parameters were analyzed using Spearman's rank correlation to remove confounding variables. (**f**,**g**) Statistical analyses were performed using the stepwise variable selection method, change-score analysis, and GAMs.](srep13315-f1){#f1}

![STFT along with a spectrogram and fixed window size can be used for localizing signals.\
*w*(*t*) and *x*(*t*) denote the window and EEG signal, respectively, and the EEG signals are expressed in the time--frequency domain.](srep13315-f2){#f2}

![Functional alpha activity computation flowchart.\
(**a**) The input EEG signals were obtained from 19 electrodes of the international standard 10--20 systems. (**b**) The data were passed through a low-pass filter (LPF) with a cutoff frequency of 55 Hz. (**c**) STFT is presented as a spectrogram. (**d**) The AAR was investigated by comparing the alpha band (8--12 Hz) with the full-band EEG (1--55 Hz). (**e**,**f**) AAR~th~ is a threshold and (**g**,**h**) denotes the energy change at a significant level for all channels.](srep13315-f3){#f3}

###### Demographic data of the patients.

                                                                   Total patients(n=84)   Revascularization treatment                
  --------------------------------------------------------------- ---------------------- ----------------------------- ------------- -------------
  Male/female                                                             70/14                      12/7                  58/7       P = 0.0133
  Age                                                                  64.2 ± 11.9                62.6 ± 10.7           64.6 ± 12.3   P = 0.5634
  Body mass index                                                       26.8 ± 3.6                28.2 ± 3.6            26.3 ± 3.50   P = 0.0563
  Estimated glomerular filtration rate                                 1(24)/0(60)                1(19)/0(46)           1(5)/0(14)       P = 1
  Fasting glucose                                                        135 ± 37                  167 ± 51              131 ± 34     P = 0.1088
  Triglyceride                                                           166 ± 88                  168 ± 90              165 ± 88     P = 0.9531
  Total cholesterol                                                      167 ± 38                  173 ± 28              166 ± 41     P = 0.1473
  Uric acid                                                             8.7 ± 15.5                9.4 ± 11.0            8.5 ± 16.7    P = 0.1472
  Mean arterial blood pressure (before cardiac catheterization)        96.4 ± 12.2                93.7 ± 11.3           97.2 ± 12.5   P = 0.3522
  Mean arterial blood pressure (after cardiac catheterization)         92.5 ± 11.8                92.1 ± 9.6            92.6 ± 12.4   P = 0.8937
  Hypertension                                                          1(75)/0(9)                1(17)/0(2)            1(58)/0(7)       P = 1
  Diabetes mellitus                                                    1(34)/0(50)                1(4)/0(15)            1(30)/0(35)   P = 0.06447
  High cholesterol                                                     1(66)/0(18)                1(13)/0(6)            1(53)/0(12)   P = 0.2228
  Current smoker                                                       1(49)/0(35)                1(10)/0(9)            1(39)/0(26)   P = 0.6046
  Heart failure                                                        1(12)/0(72)                1(3)/0(16)            1(9)/0(56)       P = 1
  Peripheral arterial occlusive disease                                 1(2)/0(82)                1(0)/0(19)            1(2)/0(63)       P = 1

###### Effect of the revascularization treatment on the autonomic activities, brain waves and serum neurotransmitter.

                                    Total patients(n=84)   Revascularization treatment                     
  -------------------------------- ---------------------- ----------------------------- ------------------ ------------
  Serum neurotransmitter                                                                                   
   Dopamine                            212.9 ± 220.8             148.96 ± 201.66         231.60 ± 224.09    P = 0.0470
   Orphanin-FQ                          86.7 ± 75.8               77.51 ± 80.45           89.44 ± 74.77     P = 0.7003
   Serotonin                           176.8 ± 140.8             153.76 ± 150.69         183.56 ± 138.26    P = 0.2049
  EEG                                                                                                      
   Alpha activity (pre-)                 12.8 ± 6.1                13.3 ± 6.2               12.7 ± 6.2      P = 0.6629
   Alpha activity (post-)                14.8 ± 4.9                16.7 ± 2.7               14.2 ± 5.4      P = 0.2321
   Alpha activity (Difference-)          1.9 ± 5.5                  3.4 ± 5.2               1.6 ± 5.5       P = 0.2870
  ECG (Linear variable)                                                                                    
   meanNN (pre-)                       910.5 ± 141.1             954.3  ± 127.6           897.7 ± 143.2     P = 0.0932
   meanNN (post-)                      903.0 ± 147.2              942.1 ± 102.3           891.6 ± 156.8     P = 0.1290
   Log-meanNN (pre-)                     6.8  ± 0.2                 6.9 ± 0.1               6.8 ± 0.2       P = 0.0932
   Log-meanNN (post-)                    6.7 ± 0.2                  6.8 ± 0.1               6.8 ± 0.2       P = 0.1290
   sdNN (pre-)                          97.1 ± 63.8               118.8 ± 69.8             90.8 ± 61.0      P = 0.0871
   sdNN (post-)                         98.8 ± 66.8               115.1 ± 62.2             94.1 ± 67.8      P = 0.0708
   Log-sdNN (pre-)                       4.4 ± 0.6                  4.6 ± 0.7               4.3 ± 0.6       P = 0.0871
   Log-sdNN (post-)                      4.4 ± 0.5                  4.6 ± 0.5               4.3 ± 0.6       P = 0.0708
   pNN20 (pre-)                       0.3885 ± 0.2393            0.4974 ± 0.2553         0.3567 ± 0.2267    P = 0.0262
   pNN20 (post-)                      0.3829 ± 0.2550               0.5 ± 0.2               0.4 ± 0.3       P = 0.0708
   Log-pNN20 (pre-)                     −1.19 ± 0.77              −0.87 ± 0.68             −1.27 ± 0.77     P = 0.0262
   Log-pNN20 (post-)                    −1.30 ± 0.98               −0.9 ± 0.6               −1.4 ± 1.0      P = 0.0708
   pNN50 (pre-)                       0.1619 ± 0.2271            0.2414 ± 0.2911         0.1387 ± 0.2016    P = 0.1111
   pNN50 (post-)                      0.1689 ± 0.2286            0.2158 ± 0.2442         0.1552 ± 0.2239    P = 0.0912
   Log-pNN50 (pre-)                     −2.78 ± 1.52              −2.39 ± 1.83             −2.89 ± 1.41     P = 0.1111
   Log-pNN50 (post-)                    −2.71 ± 1.52              −2.20 ± 1.29             −2.86 ± 1.55     P = 0.0912
   rMMSD (pre-)                         111.3 ± 99.9              136.4 ± 109.3            104.0 ± 96.7     P = 0.2755
   rMMSD (post-)                       113.8 ± 103.6              126.5 ± 91.0            110.1 ± 107.4     P = 0.3359
   Log-rMMSD (pre-)                      4.4 ± 0.8                  4.6 ± 0.9               4.4 ± 0.7       P = 0.2755
   Log-rMMSD (post-)                     4.4 ± 0.8                  4.6 ± 0.8               4.4 ± 0.8       P = 0.3386
   LF (pre-)                          2158.9 ± 6160.9           4465.3 ± 11862.0         1484.7 ± 2758.8    P = 0.2311
   LF (post-)                         6704.0 ± 10244.4          11857.8 ± 15274.0        5197.5 ± 7765.2    P = 0.0517
   Log-LF (pre-)                         6.4 ± 1.5                  6.8 ± 1.8               6.3 ± 1.4       P = 0.2311
   Log-LF (post-)                        8.0 ± 1.3                  8.6 ± 1.4               7.8 ± 1.3       P = 0.0517
   HF (pre-)                          4112.9 ± 15952.1          6344.1 ± 18366.6         3460.8 ± 15271.9   P = 0.4542
   HF (post-)                         8774.7 ± 14684.1          13801.1 ± 20361.2        7305.4 ± 12383.2   P = 0.2755
   Log-HF (pre-)                         6.5 ± 1.7                  6.8 ± 2.1               6.4 ± 1.6       P = 0.4542
   Log-HF (post-)                        8.0 ± 1.5                  8.5 ± 1.6               7.9 ± 1.5       P = 0.2755
   LF/HF (pre-)                          1.0 ± 0.5                  1.1 ± 0.5               1.0 ± 0.5       P = 0.5212
   LF/HF (post-)                         1.1 ± 0.6                  1.3 ± 0.8               1.0 ± 0.5       P = 0.2616
   Log-LF/HF (pre-)                   −0.1127 ± 0.5095          −0.0133 ± 0.4433         −0.1416 ± 0.5268   P = 0.5212
   Log-LF/HF (post-)                  −0.0402 ± 0.5222           0.1148 ± 0.5398         −0.0856 ± 0.5123   P = 0.2616
   meanNN (Difference-)                 −7.4 ± 94.73              −12.2 ± 62.4             −6.1 ± 102.6     P = 0.7322
   Log-meanNN (Difference-)             −0.01 ± 0.10              −0.01 ± 0.06             −0.01 ± 0.11     P = 0.5782
   sdNN (Difference-)                   1.73 ± 45.1                −3.7 ± 59.9              3.3 ± 40.2      P = 0.7810
   Log-sdNN (Difference-)              0.011 ± 0.432              0.026 ± 0.474           0.008 ± 0.416     P = 0.9318
   pNN20 (Difference-)                  −0.01 ± 0.17             −0.021 ± 0.149           0.001 ± 0.181     P = 0.6767
   Log-pNN20 (Difference-)              −0.12 ± 0.63              −0.03 ± 0.38             −0.14 ± 0.69     P = 0.5212
   pNN50 (Difference-)                  0.01 ± 0.16               −0.02 ± 0.19             0.02 ± 0.15      P = 0.5782
   Log-pNN50 (Difference-)              0.07 ± 1.06                0.19 ± 1.14             0.03 ± 1.04      P = 0.3924
   rMMSD (Difference-)                   2.4 ± 64.3                −9.9 ± 91.0              6.1 ± 54.6      P = 0.6457
   Log-rMMSD (Difference-)            0.0036 ± 0.5814            0.0142 ± 0.6444         0.0005 ± 0.5671    P = 0.7322
   LF (Difference-)                   4545.1 ± 11820.4          7392.5 ± 20403.7         3712.8 ± 7810.5    P = 0.0932
   Log-LF (Difference-)                  1.6 ± 1.7                  1.8 ± 1.9               1.5 ± 1.6       P = 0.2802
   HF (Difference-)                  4661.7 ± 21113.67          7457.0 ± 28693.2         3844.7 ± 18535.9   P = 0.3253
   Log-HF (Difference-)                  1.5 ± 1.8                  1.7 ± 2.0               1.5 ± 1.7       P = 0.6380
   LF/HF (Difference-)                  0.09 ± 0.52                0.21 ± 0.63             0.06 ± 0.48      P = 0.0891
   Log-LF/HF (Difference-)              0.07 ± 0.43                0.12 ± 0.45             0.06 ± 0.42      P = 0.1415
  ECG (Nonlinear variable)                                                                                       
   Slopes 1--5 (pre-)                 0.0029 ± 0.0713           −0.0122 ± 0.0843          0.0073 ± 0.067    P = 0.4738
   Slopes 1--5 (post-)                0.0037 ± 0.0819            0.0253 ± 0.0970         −0.0025 ± 0.0767   P = 0.2898
   Slopes 6--20 (pre-)                0.0049 ± 0.0166           −0.0011 ± 0.0179         0.0067 ± 0.0159    P = 0.1136
   Slopes 6--20 (post-)               0.0096 ± 0.0173            0.0060 ± 0.0187         0.0106 ± 0.0169    P = 0.2947
   Area 1--5 (pre-)                     4.07 ± 1.44                4.47 ± 1.72             3.95 ± 1.34      P = 0.3359
   Area 1--5 (post-)                    3.94 ± 1.52                4.28 ± 1.89             3.84 ± 1.39      P = 0.2616
   Log_Area 1--5 (pre-)                  3.1 ± 4.9                 2.58 ± 3.43              3.3 ± 5.2       P = 0.4607
   Log_Area 1--5 (post-)                 3.1 ± 5.1                  2.8 ± 4.6               3.2 ± 5.2       P = 0.3749
   Area 6--20 (pre-)                     14.7 ± 6.8                15.7 ± 6.5               14.4 ± 6.9      P = 0.4938
   Area 6--20 (post-)                    14.9 ± 7.2                16.3 ± 7.8               14.5 ± 7.1      P = 0.1995
   Log_Area 6--20 (pre-)                 2.8 ± 0.3                  2.8 ± 0.3               2.7 ± 0.4       P = 0.7892
   Log_Area 6--20 (post-)                2.7 ± 0.4                  2.8 ± 0.6               2.7 ± 0.4       P = 0.2149
   ∝~1~ (pre-)                          0.75 ± 0.19                0.78 ± 0.21             0.74 ± 0.18      P = 0.5422
   ∝~1~ (post-)                         0.78 ± 0.21                0.83 ± 0.22             0.76 ± 0.20      P = 0.2708
   Log\_∝~1~ (pre-)                     −0.32 ± 0.29              −0.28 ± 0.29             −0.33 ± 0.30     P = 0.5422
   Log\_∝~1~ (post-)                    −0.29 ± 0.32              −0.21 ± 0.28             −0.32 ± 0.33     P = 0.2708
   ∝~2~ (pre-)                          0.78 ± 0.13                0.78 ± 0.14             0.77 ± 0.13      P = 0.6611
   ∝~2~ (post-)                         0.75 ± 0.12                0.72 ± 0.13             0.75 ± 0.12      P = 0.2898
   Log\_∝~2~ (pre-)                     −0.27 ± 0.16              −0.26 ± 0.18             −0.27 ± 0.16     P = 0.6611
   Log\_∝~2~ (post-)                    −0.31 ± 0.17              −0.34 ± 0.17             0.29 ± 0.17      P = 0.2898
   Slopes 1--5 (Difference-)          0.0008 ± 0.0776            0.0375 ± 0.0878         −0.0098 ± 0.0716   P = 0.0833
   Slopes 6--20 (Difference-)         0.0046 ± 0.0168            0.0072 ± 0.0171         0.0038 ± 0.0168    P = 0.6611
   Areas 1--5 (Difference-)             −0.13 ± 1.25              −0.19 ± 1.13             −0.11 ± 1.29     P = 0.8979
   Log_Areas 1--5 (Difference-)       −0.0044 ± 1.2235           0.2118 ± 1.4369         −0.0676 ± 1.1587   P = 0.6845
   Areas 6--20 (Difference-)             0.2 ± 4.7                  0.6 ± 4.2               0.1 ± 4.9       P = 0.8223
   Log_Areas 6--20 (Difference-)        −0.01 ± 0.41             −0.008 ± 0.418           −0.009 ± 0.414    P = 0.6304
   ∝~1~ (Difference-)                   0.02 ± 0.17                0.05 ± 0.14             0.02 ± 0.18      P = 0.2997
   Log-∝~1~ (Difference-)               0.03 ± 0.25               0.071 ± 0.175           0.013 ± 0.263     P = 0.3253
   ∝~2~ (Difference-)                   −0.03 ± 0.13              −0.06 ± 0.13             −0.02 ± 0.13     P = 0.2482
   Log- ∝~2~ (Difference-)              −0.04 ± 0.18             10.074 ± 0.175           −0.030 ± 0.179    P = 0.3306

###### Multiple regression analysis of the difference-alpha activity.

  Parameter                **Total patients (N** **=** **84)**                    
  ----------------------- ------------------------------------- -------- -------- -------------
  (Intercept)                            3.2361                  3.0405   1.064    p = 0.2905
  meanNN (Pre-)                          0.0124                  0.0029   4.350    p \< 0.0001
  Slope1_5 (Pre-)                       −12.6317                 5.4399   −2.322   p = 0.0229
  Log_Area 1_5 (Pre-)                    0.1948                  0.0760   2.562    p = 0.0124
  Alpha_activity (Pre-)                  −0.5329                 0.0611   −8.717   p \< 0.0001
  meanNN (Difference)                    0.0201                  0.0043   4.688    p \< 0.0001
  Age                                    −0.0963                 0.0329   −2.931   p = 0.0045

Residual standard error: 3.3572 on 77 degrees of freedom.

Multiple R-squared: 0.6509, Adjusted R-squared: 0.6237.

F-statistic: 23.9266 on 6 and 77 DF, p-value \< 0.0001.

###### Multiple regression analysis of the difference-alpha activity using GAMs.

  Parameter                                                    **Total patients (N** **=** **84)**                     
  ----------------------------------------------------------- ------------------------------------- -------- --------- ------------
  (Intercept)                                                                0.9668                  2.7122    0.356    p = 0.7225
  meanNN (Pre-)                                                              0.0104                  0.0026    3.992    p = 0.0002
  Slope1_5 (Pre-)                                                           −15.7228                 4.9149   −3.199    p = 0.0021
  Alpha_activity (Pre-)                                                      −0.5704                 0.0555   −10.278   p\< 0.0001
  meanNN (Difference)                                                        0.0219                  0.0039    5.597    p\< 0.0001
  LF_HF (Difference)                                                         −2.8915                 0.7175   −4.030    p = 0.0001
  0.017 ≤pNN50(Pre-) ≤ 0.176                                                 1.9557                  0.6820    2.867    p = 0.0054
  1.229 ≤LF/HF (Pre-) ≤1.98                                                  1.9867                  0.8599    2.310    p = 0.0237
  2.183 ≤ Log -Area(Pre-) ≤ 2.895                                            2.0038                  0.7134    2.809    p = 0.0064
  −0.164 ≤ pNN20 (Difference) ≤ 0.007                                        1.5934                  0.6858    2.323    p = 0.0230
  HF (Difference) ≤ 376.933 and HF (Difference) ≥ 25327.388                  2.5186                  0.6999    3.598    p = 0.0006
  Age                                                                        −0.0776                 0.0309   −2.506    p = 0.0145

Residual standard error: 2.9466 on 72 degrees of freedom.

Multiple R-squared: 0.7485, Adjusted R-squared: 0.7101.

F-statistic: 19.4842 on 11 and 72 DF, p-value: 0.

###### Change-score analysis performed using GAMs without considering the pre-alpha activity.

  Parameter                                                    **Total patients (N** **=** **84)**                     
  ----------------------------------------------------------- ------------------------------------- --------- -------- ------------
  (Intercept)                                                                −7.3293                 3.5819    −2.046   p = 0.0444
  meanNN (Pre-)                                                              0.0091                  0.0037    2.449    p = 0.0170
  sdNN (Pre-)                                                                0.0369                  0.0168    2.193    p = 0.0326
  pNN20 (Pre-)                                                               −9.8173                 4.4838    −2.190   p = 0.0320
  Slope1_5 (Pre-)                                                           −36.8229                 9.0475    −4.070   p = 0.0001
  meanNN (Difference)                                                        0.0176                  0.0057    3.102    p = 0.0028
  LF/HF (Difference)                                                         −2.7241                 0.9346    −2.915   p = 0.0048
  3.81 ≤ Log_rMSSD (Pre-) ≤ 5.348                                            2.6421                  1.0521    2.511    p = 0.0143
  1.229 ≤ LF/HF (Pre-) ≤ 1.98                                                2.6666                  1.2603    2.116    p = 0.0379
  Log_Area 1\~5 (Pre-) ≤ 1.007                                               −4.2005                 1.7325    −2.425   p = 0.0179
  HF (Difference) ≤ 376.933 and HF (Difference) ≥ 25327.388                  2.7330                  1.08173   2.526    p = 0.0138
  Hypertension                                                               −3.5953                 1.3556    −2.652   p = 0.0099
  Log-Serotonin                                                              0.5052                  0.2083    2.426    p = 0.0178

Residual standard error: 4.1893 on 71 degrees of freedom.

Multiple R-squared: 0.4988, Adjusted R-squared: 0.414.

F-statistic: 5.8875 on 12 and 71 DF, p-value: 0.

[^1]: These authors are contributed equally to this work.
